(Q43067830)

13 November 2017

Fenofibrate-induced liver injury (English)

1 reference

13 November 2017

Kazufumi Dohmen

1

1 reference

13 November 2017

Chun Yang Wen

2

1 reference

13 November 2017

Shinya Nagaoka

3

1 reference

13 November 2017

Koji Yano

4

1 reference

13 November 2017

Seigo Abiru

5

1 reference

13 November 2017

Toshihito Ueki

6

1 reference

13 November 2017

Atsumasa Komori

7

1 reference

13 November 2017

Manabu Daikoku

8

1 reference

13 November 2017

Hiroshi Yatsuhashi

9

1 reference

13 November 2017

Hiromi Ishibashi

10

1 reference

13 November 2017

language of work or name

English

0 references

publication date

1 December 2005

1 reference

World Journal of Gastroenterology

13 November 2017

1 reference

13 November 2017

11

1 reference

13 November 2017

48

1 reference

13 November 2017

7702-7703

1 reference

Fenofibrate for patients with asymptomatic primary biliary cirrhosis

13 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4727212

A novel treatment for refractory primary biliary cirrhosis?

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4727212

Fenofibrate treatment in patients with primary biliary cirrhosis

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4727212

Is bezafibrate histologically effective for primary biliary cirrhosis?

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4727212

Simvastatin in primary biliary cirrhosis: effects on serum lipids and distinct disease markers

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4727212

Fenofibrate modifies transaminase gene expression via a peroxisome proliferator activated receptor α-dependent pathway

15 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.3748%2FWJG.V11.I48.7702

Bezafibrate in the treatment of primary biliary cirrhosis: comparison with ursodeoxycholic acid

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16437706

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16437706

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Combination therapy of bezafibrate and ursodeoxycholic acid in primary biliary cirrhosis: a preliminary study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16437706

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3748/WJG.V11.I48.7702

1 reference

13 November 2017

1 reference

13 November 2017

PubMed publication ID

16437706

1 reference